THU0332 Fatigue remains a dominatng symptom despite tumour necrosis factor inhibitor therapy in psoriatic arthritis: a population-based cohort study

Inhibitor Therapy ◽

Factor Inhibitor ◽

OP0106 The impact of comorbidities on effect and discontinuation of tumour necrosis factor inhibitor therapy in psoriatic arthritis: a population-based cohort study

10.1136/annrheumdis-2017-eular.1500 ◽

2017 ◽

Author(s):

C Ballegaard ◽

P Højgaard ◽

L Dreyer ◽

R Cordtz ◽

TS Jørgensen ◽

...

Keyword(s):

Cohort Study ◽

Psoriatic Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Population Based ◽

Inhibitor Therapy ◽

Factor Inhibitor ◽

The Impact ◽

FRI0518 Prescription patterns of tumour necrosis factor inhibitor and ustekinumab in psoriatic arthritis: a nordic population-based cohort study

10.1136/annrheumdis-2017-eular.4690 ◽

2017 ◽

Cited By ~ 2

Author(s):

TS Jørgensen ◽

L Dreyer ◽

B Guðbjörnsson ◽

ML Hetland ◽

B Glintborg ◽

...

Keyword(s):

Cohort Study ◽

Psoriatic Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Population Based ◽

Prescription Patterns ◽

Factor Inhibitor ◽

248 Sustained improvements in disease activity for up to two-years with ixekizumab in patients with active psoriatic arthritis who were either biologic-naïve or with previous inadequate response to tumour necrosis factor inhibitor therapy

Rheumatology ◽

10.1093/rheumatology/kez107.064 ◽

2019 ◽

Vol 58 (Supplement_3) ◽

Author(s):

Deepak R Jadon ◽

Mani Haschemi Nassab ◽

Katrien Van Beneden ◽

Georg Pum ◽

Andrew J Bradley

Keyword(s):

Psoriatic Arthritis ◽

Disease Activity ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Inhibitor Therapy ◽

Inadequate Response ◽

Factor Inhibitor ◽

OP0261 RISK OF NEUROLOGICAL ADVERSE EVENTS DURING TUMOUR NECROSIS FACTOR INHIBITOR TREATMENT FOR ARTHRITIS: A POPULATION-BASED COHORT STUDY FROM DANBIO AND ARTIS

10.1136/annrheumdis-2019-eular.1747 ◽

2019 ◽

Author(s):

Tine Iskov Kopp ◽

Elizabeth Arkema ◽

René Cordtz ◽

Bénédicte Delcoigne ◽

Johan Askling ◽

...

Keyword(s):

Cohort Study ◽

Adverse Events ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Population Based ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Inhibitor Treatment

OP0201 A phase 3 study of the efficacy and safety of ixekizumab in patients with active psoriatic arthritis and inadequate response to tumour necrosis factor inhibitor(s)

10.1136/annrheumdis-2017-eular.1576 ◽

2017 ◽

Cited By ~ 1

Author(s):

P Nash ◽

B Kirkham ◽

M Okada ◽

P Rahman ◽

B Combe ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Inadequate Response ◽

Efficacy And Safety ◽

Phase 3 ◽

Factor Inhibitor ◽

FRI0098 Elevated multi-biomarker disease activity (MBDA) predicts relapses in ra patients in sustained remission tapering tumour necrosis factor inhibitor therapy- results from the randomized controlled retro study

10.1136/annrheumdis-2017-eular.4787 ◽

2017 ◽

Author(s):

J Rech ◽

M Hagen ◽

M Englbrecht ◽

J Haschka ◽

M Reiser ◽

...

Keyword(s):

Disease Activity ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Inhibitor Therapy ◽

Sustained Remission ◽

Randomized Controlled ◽

Factor Inhibitor ◽

Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-208490 ◽

2015 ◽

Vol 75 (4) ◽

pp. 785-786 ◽

Cited By ~ 18

Author(s):

L Dreyer ◽

M Magyari ◽

B Laursen ◽

R Cordtz ◽

F Sellebjerg ◽

...

Keyword(s):

Multiple Sclerosis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Population Based ◽

Population Based Study ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Inhibitor Treatment

Defective CD8+CD28−regulatory T cell suppressor function in rheumatoid arthritis is restored by tumour necrosis factor inhibitor therapy

Clinical & Experimental Immunology ◽

10.1111/cei.12161 ◽

2013 ◽

Vol 174 (1) ◽

pp. 18-26 ◽

Cited By ~ 23

Author(s):

S. Ceeraz ◽

C. Hall ◽

E. H. Choy ◽

J. Spencer ◽

V. M. Corrigall

Keyword(s):

Rheumatoid Arthritis ◽

T Cell ◽

Tumour Necrosis Factor ◽

Regulatory T Cell ◽

Tumour Necrosis ◽

Inhibitor Therapy ◽

Suppressor Function ◽

Factor Inhibitor ◽

Long-term work disability in patients with psoriatic arthritis treated with anti-tumour necrosis factor: a population-based regional Swedish cohort study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2012-202229 ◽

2012 ◽

Vol 72 (10) ◽

pp. 1675-1679 ◽

Cited By ~ 23

Author(s):

Lars Erik Kristensen ◽

Martin Englund ◽

Martin Neovius ◽

Johan Askling ◽

Lennart T H Jacobsson ◽

...

Keyword(s):

Cohort Study ◽

Psoriatic Arthritis ◽

Tumour Necrosis Factor ◽

Work Disability ◽

Tumour Necrosis ◽

Population Based ◽

Necrosis Factor ◽

Swedish Cohort

Impact of Comorbidities on Tumor Necrosis Factor Inhibitor Therapy in Psoriatic Arthritis: A Population-Based Cohort Study

Arthritis Care & Research ◽

10.1002/acr.23333 ◽

2018 ◽

Vol 70 (4) ◽

pp. 592-599 ◽

Cited By ~ 24

Author(s):

Christine Ballegaard ◽

Pil Højgaard ◽

Lene Dreyer ◽

René Cordtz ◽

Tanja Schjødt Jørgensen ◽

...

Keyword(s):

Cohort Study ◽

Psoriatic Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Inhibitor ◽

Population Based ◽

Inhibitor Therapy ◽

Factor Inhibitor ◽